Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-05-11

Posted on May 11, 2026August 3, 2026 By K-STOCK Editor No Comments on [Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-05-11

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Daeduck Electronics decided to invest KRW 213.0B, equivalent to 23.74% of its equity, in expanding its semiconductor manufacturing plant and auxiliary facilities to meet growing market demand.

📊 Key Disclosure Contents & Major Figures

1. Investment Purpose and Scope

  • Investment Classification: Facility expansion
  • Investment Target: Semiconductor product production plant expansion
  • Investment Purpose: Production plant expansion to respond to increasing demand in the semiconductor market

2. Investment Amount and Equity Ratio

  • Investment Amount: KRW 213.0B (KRW 213,000,000,000)
  • Total Equity: KRW 897.31B (KRW 897,305,160,164) / (Based on FY2025 K-IFRS consolidated financial statements)
  • Ratio to Equity: 23.74%
  • Large Corporation Status: N/A

3. Investment Period and Financing Plan

  • Investment Period: May 11, 2026 ~ December 31, 2027
  • Financing Plan: To be funded through internal cash reserves and external borrowings

4. Board Resolution & Other Reference Details

  • Board Resolution Date: May 11, 2026
  • Board Attendance Status: Outside Directors: 1 Present, Auditor: Present
  • Investment Start Date: Board resolution date (May 11, 2026)
  • Other Matters: The detailed investment breakdown is KRW 213.0B for factory expansion and auxiliary facilities. The investment amount and period are subject to change during implementation.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Facility Investment Execution and Progress

This disclosure reports the decision on facility expansion for semiconductor manufacturing plants, along with the planned investment period and financing methods. Checking whether the facility investment and capital procurement proceed according to the disclosed schedule is important to verify whether the transaction is completed as planned. Relevant details can be verified in future subsequent disclosures or periodic reports including annual, semi-annual, or quarterly reports.

📢 Disclaimer & Source Notice

Fact Source: Financial Supervisory Service DART

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] PSK Holdings (031980) – Investor Relations (IR) Host / 2026-05-11
Next Post: [Disclosure] Hanwha Aerospace (012450) Announces Expiration of Mandatory Retention (Lock-up) Period for 1.71M Common Shares Issued via Third-Party Placement

Related Posts

[Disclosure] SK Square (402340) – Clarification on Rumors or Reports / 2024-11-06 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Rescinds Record Date for Paid-in Capital Increase Due to Schedule Changes Disclosures
[Disclosure] SK square (402340) – Decision on Acquisition of Shares and Equity Securities of Other Corporations / 2026-01-28 Semiconductors
[Disclosure] SK hynix (000660) – Report on Reasons for Holding AGM on Concentrated Date  / 2026-02-25 Semiconductors
[Disclosure] SK hynix (000660) – Decision on Acquisition of Shares and Investment Securities of Other Corporation / 2026-01-28 Semiconductors
[Disclosure] Hanwha Aerospace (012450) – (Correction) Change in Revenue or Profit/Loss Structure over 30% (Clerical Error Correction & FY2023 Consolidated Revenue KRW 9.37T, Operating Profit KRW 701.7B) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme